Entrada Therapeutics, Inc. (TRDA) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts TRDA Hot Sheet
Join SI Premium – FREE
Entrada Therapeutics, Inc. (NASDAQ: TRDA) reported Q1 EPS of ($0.95), $0.07 better than the analyst estimate of ($1.02). Revenue for the quarter came in at $875 thousand versus the consensus estimate of $3.34 million.
For earnings history and earnings-related data on Entrada Therapeutics, Inc. (TRDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dingdong (DDL) Reports Q2 EPS of RMB0.90
- Alibaba (BABA) Misses Q2 EPS by 220c
- J.M. Smucker (SJM) PT Raised to $142 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
